Category:

European regulators have approved Bristol-Myers Squibb’s Evotaz for the treatment of … HIV-1…once-daily therapy combines atazanavir,.. and cobicistat,.. there are 2.2 million HIV-infected individuals in the E.U. …those who are not resistant to protease inhibitors, Evotaz represents an important new treatment option that may help them attain and retain virologic suppression.

Novartis's new heart failure drug, sacubitril and valsartan (Entresto),..is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure...and reduced ejection fraction.

By performing medication reconciliation across the care continuum, pharmacists play an essential role in preventing medication errors during transitions of care. Pharmacy professors from the Lloyd L. Gregory School of Pharmacy at Palm Beach Atlantic University recently detailed the most common causes of medication errors during care transitions and described the pharmacists’ role in mitigating them.